Modification of deceleration zones and late potentials after ventricular tachycardias substrate ablation

Back

EHRA 2024 Premium Access

Modification of deceleration zones and late potentials after ventricular tachycardias substrate ablation

Session: Ventricular tachycardia 3

Topic: Ablation of Ventricular Arrhythmias

Speaker: Doctor P. China (Mestre-Venice, IT)

Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Paolo China

Hospital dell'Angelo, Mestre-Venice (Italy)

1 presentation

0 follower

8 more presentations in this session

An optimized multisource acquisition and registration workflow for imaging guided ventricular tachycardia ablation

Speaker: Doctor M. Parollo (Pisa, IT)

Lower dose radiotherapy did not alter cardiac function and was not pro-arrhythmic: results of the small prospective HALO trial

Speaker: Mr W. Hoeksema (Amsterdam, NL)

The evaluation of the efficacy of automated peak frequency annotation algorithm for the identification of critical isthmus of ventricular tachycardia and deceleration zones

Speaker: Professor H. Yorgun (Ankara, TR)

Genotype, phenotype and outcomes of patients with hypertrophic cardiomyopathy referred for ablation of ventricular tachycardia

Speaker: Doctor A. Meretta (Leiden, NL)

Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED-Registry)

Speaker: Doctor J. van den Bruck (Cologne, DE)

Access the full session

Ventricular tachycardia 3

Speakers: Doctor P. China, Doctor M. Parollo, Mr W. Hoeksema, Professor H. Yorgun, Doctor A. Meretta...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

Modification of deceleration zones and late potentials after ventricular tachycardias substrate ablation

About the speaker

Doctor Paolo China

8 more presentations in this session

An optimized multisource acquisition and registration workflow for imaging guided ventricular tachycardia ablation

Lower dose radiotherapy did not alter cardiac function and was not pro-arrhythmic: results of the small prospective HALO trial

The evaluation of the efficacy of automated peak frequency annotation algorithm for the identification of critical isthmus of ventricular tachycardia and deceleration zones

Genotype, phenotype and outcomes of patients with hypertrophic cardiomyopathy referred for ablation of ventricular tachycardia

Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED-Registry)

Access the full session

Ventricular tachycardia 3

About the event

EHRA 2024

ESC 365 is supported by